ICH Official web site : ICH
WEBThe Formal ICH Procedure is a step-wise procedure consisting of 5 steps (see below, click to have information on a particular step). This procedure is followed for the harmonisation of all new ICH topics.
WEBIt is important to determine the relevant inputs that affect the model performance, based on appropriate approaches such as sensitivity analysis. Model performance depends on factors such as mathematical constructs and the quality of model inputs (e.g., noise, variability of data).
WEBICH Process - Topic selection • Any ICH Member and Observer can submit proposals for an ICH work product (New guideline, Q&A, revision of existing guideline) • The ICH Assembly reviews topic proposals once per year and selects new topics for harmonisation during an Assembly meeting (i.e. ICH E6(R3) selected in June 2019 in Europe meeting)
WEBThe Quality Target Product Profile (QTPP) and potential CQAs of the drug product (as defined in ICH Q8) can help identify potential CQAs of the drug substance. Knowledge and understanding of the CQAs can evolve during the course of development. 3.1.2.
WEBICH Q7 describe the Change Control activities linked to GMP and Quality System elements. ICH Q10 describe the Change Management: ICH Q10: ‘Innovation, continual improvement, the outputs of process performance and product quality monitoring and CAPA drive change’ (ICH Q10: 3.2.3) A life cycle activity.
WEBThis document (Guide) is intended to provide guidance regarding good manufacturing practice (GMP) for the manufacturing of active pharmaceutical ingredients (APIs) under an appropriate system for managing quality.
WEBAt Step 2 of the ICH Process, a consensus draft text or guideline, agreed by the appropriate ICH Expert Working Group, is transmitted by the ICH Assembly to the regulatory authorities of the ICH regions for internal and external consultation, according to national or regional procedures.
- [PDF]
Overview of ICH
WEBICH has achieved international harmonisation of technical guidelines, with engagement of regulators and industry. ICH has clear governance and increasingly global membership following ICH reform. Five transparent steps in the …
The ICH Q9(R1) Guideline reaches Step 4 of the ICH Process
WEBJan 18, 2023 · The ICH Q9(R1) Guideline on Quality Risk Management has reached Step 4 of the ICH Process on 18 January 2023. This Guideline is intended to provide guidance on the principles and examples of tools for quality risk management that can be applied to different aspects of pharmaceutical quality.
WEBThe elements of ICH Q10 should be applied in a manner that is appropriate and proportionate to each of the product lifecycle stages, recognizing the differences among, and the different goals...